Costly drugs force life-death decisions
(AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20060812/ap_on_he_me/spending_to_death"><img src="http://d.yimg.com/us.yimg.com/p/ap/20060812/capt.nyol70108121814.spending_to_death_nyol701.jpg?x=130&y=92&sig=_YxvWoRFPW8qXZFrUFjIkg--" align="left" height="92" width="130" alt="Bottles of pills line the counter of Rebecca Dague's kitchen in Medina, Ohio, in this May 17, 2006 file photo. Dague takes an array of supplements in addition to the expensive drug, Erbitux, to treat her colon cancer. (AP Photo/Mark Duncan, File)" border="0" /></a>AP - Dying of lung cancer, Carolyn Hobbs tried a new biotechnology drug that produced an unanticipated side effect: acute sticker shock. She was waiting for her second treatment in a hospital near Denver less than two years ago, when someone from the business office marched in to warn that her share would cost more than $18,000, since the drug wasn't insured for her type of cancer.</p><br clear="all"/>